Derek Cameron Leslie
Direktor/Vorstandsmitglied bei Glykogen Ltd.
Ursprung des Netzwerks ersten Grades von Derek Cameron Leslie
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Glykogen Ltd.
Glykogen Ltd. Pharmaceuticals: MajorHealth Technology Glykogen Ltd. engages in the development of anti-glycan monoclonal antibodies using a novel and innovative process. The company was founded on October 11, 2016 and is headquartered in Fife, the United Kingdom.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Derek Cameron Leslie
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
The University of Edinburgh | College/University | Doctorate Degree | |
Heriot-Watt University | College/University | Undergraduate Degree | |
Luperacus Ltd.
Luperacus Ltd. BiotechnologyHealth Technology Luperacus Ltd. develops novel therapeutic antibodies to treat canine and human cancer. The company was founded by Alan G. Clark and is headquartered in Glasgow, the United Kingdom. | Biotechnology | Director/Board Member | |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
BioCaptiva Ltd.
BioCaptiva Ltd. BiotechnologyHealth Technology BioCaptiva Ltd. is a British medical device company that is developing the BioCaptis, a device that can transform liquid biopsy testing for cancer management. The company is based in Edinburgh, UK. The BioCaptis captures up to 100x more cell-free DNA (cfDNA) than a venous blood draw, yielding high-quality and quantity cfDNA for testing, which addresses the major challenge of liquid biopsy in cancer management. This will potentially allow the testing of a far greater number of cancer types and stages in a much wider range of patients. BioCaptiva was founded in 2021 when it spun out from the University of Edinburgh. The CEO is Jeremy Wheeler. | Biotechnology | Director/Board Member | |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistik
International
Vereinigtes Königreich | 7 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Operativ
Director/Board Member | 7 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Derek Cameron Leslie
- Unternehmensverbindungen